scholarly journals Evaluating noncoding nucleotide repeat expansions in amyotrophic lateral sclerosis

2014 ◽  
Vol 35 (4) ◽  
pp. 936.e1-936.e4 ◽  
Author(s):  
Matthew D. Figley ◽  
Anna Thomas ◽  
Aaron D. Gitler
2021 ◽  
Vol 4 (4) ◽  
pp. e202000764
Author(s):  
Arun Pal ◽  
Benedikt Kretner ◽  
Masin Abo-Rady ◽  
Hannes Glaβ ◽  
Banaja P Dash ◽  
...  

Intronic hexanucleotide repeat expansions (HREs) in C9ORF72 are the most frequent genetic cause of amyotrophic lateral sclerosis, a devastating, incurable motoneuron (MN) disease. The mechanism by which HREs trigger pathogenesis remains elusive. The discovery of repeat-associated non-ATG (RAN) translation of dipeptide repeat proteins (DPRs) from HREs along with reduced exonic C9ORF72 expression suggests gain of toxic functions (GOFs) through DPRs versus loss of C9ORF72 functions (LOFs). Through multiparametric high-content (HC) live profiling in spinal MNs from induced pluripotent stem cells and comparison to mutant FUS and TDP43, we show that HRE C9ORF72 caused a distinct, later spatiotemporal appearance of mainly proximal axonal organelle motility deficits concomitant to augmented DNA double-strand breaks (DSBs), RNA foci, DPRs, and apoptosis. We show that both GOFs and LOFs were necessary to yield the overall C9ORF72 pathology. Increased RNA foci and DPRs concurred with onset of axon trafficking defects, DSBs, and cell death, although DSB induction itself did not phenocopy C9ORF72 mutants. Interestingly, the majority of LOF-specific DEGs were shared with HRE-mediated GOF DEGs. Finally, C9ORF72 LOF was sufficient—albeit to a smaller extent—to induce premature distal axonal trafficking deficits and increased DSBs.


2019 ◽  
Vol 401 ◽  
pp. 51-54 ◽  
Author(s):  
Melissa Nel ◽  
Gloudi M. Agenbag ◽  
Franclo Henning ◽  
Helen M. Cross ◽  
Alina Esterhuizen ◽  
...  

2014 ◽  
Vol 71 (6) ◽  
pp. 771 ◽  
Author(s):  
Jill S. Goldman ◽  
Catarina Quinzii ◽  
Jane Dunning-Broadbent ◽  
Cheryl Waters ◽  
Hiroshi Mitsumoto ◽  
...  

2016 ◽  
Vol 79 (2) ◽  
pp. 295-305 ◽  
Author(s):  
Rachel H Tan ◽  
Jillian J Kril ◽  
Ciara McGinley ◽  
Mohammad Hassani ◽  
Masami Masuda-Suzukake ◽  
...  

Neurology ◽  
2020 ◽  
Vol 95 (24) ◽  
pp. e3394-e3405 ◽  
Author(s):  
Yanchun Yuan ◽  
Zhen Liu ◽  
Xuan Hou ◽  
Wanzhen Li ◽  
Jie Ni ◽  
...  

ObjectiveTo determine whether the GGC repeats in the NOTCH2NLC gene contribute to amyotrophic lateral sclerosis (ALS).MethodsIn this study, 545 patients with ALS and 1,305 healthy controls from mainland China were recruited. Several pathogenic mutations in known ALS-causative genes (including C9ORF72 and ATXN2) and polynucleotide repeat expansions in NOP56 and AR genes were excluded. Repeat-primed PCR and GC-rich PCR were performed to determine the GGC repeat size in NOTCH2NLC. Systematic and targeted clinical evaluations and investigations, including skin biopsy and dynamic electrophysiologic studies, were conducted in the genetically affected patients.ResultsGGC repeat expansion was observed in 4 patients (numbers of repeats 44, 54, 96, and 143), accounting for ≈0.73% (4 of 545) of all patients with ALS. A comparison with 1,305 healthy controls revealed that GGC repeat expansion in NOTCH2NLC was associated with ALS (Fisher exact test, 4 of 545 vs 0 of 1,305, p = 0.007). Compared to patients with the neuronal intranuclear inclusion disease (NIID) muscle weakness–dominant subtype, patients with ALS phenotype carrying the abnormal repeat expansion tended to have a severe phenotype and rapid deterioration.ConclusionOur results suggest that ALS is a specific phenotype of NIID or that GGC expansion in NOTCH2NLC is a factor that modifies ALS. These findings may help clarify the pathogenic mechanism of ALS and may expand the known clinical spectrum of NIID.


2016 ◽  
Vol 38 ◽  
pp. 217.e15-217.e22 ◽  
Author(s):  
Yongping Chen ◽  
Ziqiang Lin ◽  
Xueping Chen ◽  
Bei Cao ◽  
Qianqian Wei ◽  
...  

2012 ◽  
Vol 21 (11) ◽  
pp. 2497-2502 ◽  
Author(s):  
Hylke M. Blauw ◽  
Wouter van Rheenen ◽  
Max Koppers ◽  
Philip Van Damme ◽  
Stefan Waibel ◽  
...  

2021 ◽  
Vol 7 (2) ◽  
pp. e575
Author(s):  
Carlos Estevez-Fraga ◽  
Francesca Magrinelli ◽  
Davina Hensman Moss ◽  
Eoin Mulroy ◽  
Giulia Di Lazzaro ◽  
...  

ObjectiveHexanucleotide repeat expansions (HREs) in C9orf72 are a major cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). We aimed to determine the frequency and phenomenology of movement disorders (MD) in carriers of HRE in C9orf72 through a retrospective review of patients' medical records.MethodsWe retrospectively reviewed the clinical records of patients carrying a C9orf72 HRE in the pathogenic range and compared the characteristics of patients with and without MD.ResultsSeventeen of 40 patients with a C9orf72 HRE had a documented MD. In 6 of 17, MD were the presenting symptom, and in 2 of 17, MD were the sole manifestation of the disease. FTD was present in 13 of 17 patients, ALS in 5 of 17 patients, and 2 of 17 patients did not develop FTD or ALS. Thirteen of 17 patients had more than one MD. The most common MD were parkinsonism and tremor (resembling essential tremor syndrome), each one present in 11 of 17 patients. Distal, stimulus-sensitive upper limbs myoclonus was present in 6 of 17 patients and cervical dystonia in 5 of 17 patients. Chorea was present in 5 of 17 patients, 4 of whom showed marked orofacial dyskinesias. The most frequent MD combination was tremor and parkinsonism, observed in 8 of 17 patients, 5 of whom also had myoclonus. C9orf72 patients without MD had shorter follow-up times and higher proportion of ALS, although these results did not survive the correction for multiple comparisons.ConclusionsMD are frequent in C9orf72. They may precede signs of ALS or FTD, or even be present in isolation. Parkinsonism, tremor, and myoclonus are most commonly observed.


Sign in / Sign up

Export Citation Format

Share Document